Dow Up0.08% Nasdaq Down0.30%

More On RANBAXY.BO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Ranbaxy Laboratories Ltd. (RANBAXY.BO)

-BSE
604.55 Down 1.20(0.20%) Sep 19
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 107,620,000   108,017,000   124,542,000   102,295,000  
Cost of Revenue49,508,000  39,033,000  48,175,000  39,558,000  
Gross Profit 58,112,000   68,983,000   76,367,000   62,737,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses100,213,000  102,270,000  106,931,000  79,784,000  
Operating Income or Loss 7,407,000   5,747,000   17,611,000   22,511,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes7,407,000  5,747,000  17,611,000  22,511,000  
Interest Expense(1,720,000)(2,046,000)(1,367,000)(657,000)
Income Before Tax -   -   -   -  
Income Tax Expense2,961,000  2,216,000  2,939,000  1,969,000  
Minority Interest62,000  (37,000)(96,000)(97,000)
Net Income From Continuing Ops(12,172,000)(10,079,000)9,324,000  (28,900,000)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (12,110,000) (10,116,000) 9,228,000   (28,997,000)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in INR.